Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
UCB Cancels Sale of Generic-Drug Unit to Buyout Firms
Bloomberg
Wed, 12/17/14 - 08:04 am
UCB Pharmaceuticals
M&A
generics
Activis to Replace Most Allergan Executives After Deal
Bloomberg
Tue, 12/16/14 - 10:20 am
Activis
Allergan
executives
M&A
Merck looks for $8B bridge loan for Cubist acquisition
Reuters
Mon, 12/15/14 - 09:24 pm
Merck
M&A
Cubist Pharma
Medtronic launches new sinus surgery device
Mass Device
Mon, 12/15/14 - 09:21 pm
Medtronic
sinus surgery
M&A
devices
NovaShield
Banks lost big betting on canceled AbbVie-Shire merger
Fierce Pharma
Mon, 12/15/14 - 06:58 pm
AbbVie
Shire
M&A
Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics
Fierce Vaccines
Mon, 12/15/14 - 06:56 pm
Baxter International
vaccines
M&A
Vero
Nanotherapeutics
Medtech M&A explodes in 2014
Mass Device
Mon, 12/15/14 - 08:59 am
M&A
devices
Abbott Acquires Veropharm for $305M
Drug Discovery and Development
Mon, 12/15/14 - 08:30 am
Abbott Labs
M&A
Veropharma
drug manufacturing
Organovo Holdings (ONVO) CEO Hints He Is Open To Selling The Company
Bidness Etc.
Mon, 12/15/14 - 08:25 am
Organovo
M&A
Deals 'R' Us, says Sanofi chairman, pegging consumer, animal health for buys
Fierce Pharma
Thu, 12/11/14 - 11:56 am
M&A
Sanofi
consumer health
animal health
Herb Greenberg: What's Next for Valeant After Its Botched Bid for Allergan
TheStreet.com
Wed, 12/10/14 - 09:47 am
Valeant Pharmaceuticals
M&A
Allergan
Will Sanofi (SNY) Stock Advance Today on Diversification, Acquisitions Strategy?
TheStreet.com
Wed, 12/10/14 - 09:43 am
Sanofi
diversification
M&A
Shire says it's sitting on a $3B pipeline with M&A on tap
Fierce Biotech
Wed, 12/10/14 - 09:03 am
Shire
M&A
R&D
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
WSJ Online
Wed, 12/10/14 - 08:13 am
Merck
Cubist Pharma
M&A
Cubicin
antibiotics
Cubist sales force seen as potential boon for Merck intestinal drug
Yahoo/Reuters
Tue, 12/9/14 - 10:13 pm
Cubist Pharma
M&A
Merck
drug reps
Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO
Yahoo/Benzinga
Tue, 12/9/14 - 10:11 pm
Zoetis
Sanofi
Pharma CEOs
animal health
Serge Weinberg
M&A
MedTech M&A Deals Abound, Emerging Markets Promising
Investing.com
Tue, 12/9/14 - 11:47 am
M&A
devices
emerging markets
Stryker
Smith & Nephew
Tornier
Abbott Labs
Wright Medical
Covidien
Medtronic
Will Tetraphase Pharmaceuticals Be The Next Antibiotic-Maker To Be Acquired After Cubist Pharmaceuticals
Bidness Etc.
Tue, 12/9/14 - 11:40 am
Tetraphase Pharmaceuticals
Cubist Pharma
Merck
M&A
After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?
24/7 Wall St
Tue, 12/9/14 - 09:56 am
Cubist Pharma
M&A
Cempra
Achaogen
Merck says still plans Cubist purchase, despite patent setback
Yahoo/Reuters
Tue, 12/9/14 - 09:22 am
Merck
Cubist Pharma
patents
Cubicin
M&A
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »